CliffBio
small molecule

EFFEXOR XR

VENLAFAXINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyUPJOHN US 2 LLC

Drug detail

Brand nameEFFEXOR XR
Active ingredientVENLAFAXINE HYDROCHLORIDE
StrengthEQ 150MG BASE
Dosage formCAPSULE, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalOctober 1997
Marketing statusRX

More from UPJOHN US 2 LLC

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

EFFEXOR XR patent cliff — loss of exclusivity — | CliffBio